← All trials
NCT04656730
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 3, 2020
- Primary completion
- Jan 31, 2023
- Completion date
- Jan 31, 2023
- First posted
- Dec 7, 2020
- Last posted
- Sep 22, 2023
- Enrollment
- 68
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Universidad Autonoma de BarcelonaLead sponsor
- Badalona Hospital Germans Trias i PujolOverall official - principal investigator
- Universidad Autonoma de BarcelonaReponsible party - principal investigator
- Badalona Hospital Germans Trias i PujolOfficial
- Universidad Autonoma de BarcelonaSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.